Picture of Eagle Veterinary Technology Co logo

044960 Eagle Veterinary Technology Co Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapFalling Star

Momentum

Relative Strength (%)
1m-2.56%
3m+1.32%
6m-1.58%
1yr-6.59%
Volume Change (%)
10d/3m+437.2%
Price vs... (%)
52w High-31.18%
50d MA+0.92%
200d MA+0.88%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.41
Price to Tang. Book1.42
Price to Free Cashflow94.47
Price to Sales1.55
EV to EBITDA15.14

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital6.34%
Return on Equity6.41%
Operating Margin7.44%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m34,422.6840,356.5840,436.8543,539.6942,793.7n/an/a7.18%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+99.03+98+48.65-27.69+13.39n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Eagle Veterinary Technology Co EPS forecast chart

Profile Summary

Eagle Veterinary Technology Co.,Ltd is a Korea-based company engaged in the manufacture and marketing of veterinary medicines. The Company’s main products are veterinary medicines, including anthelmintics, antibiotics, analgesic agents, antibacterials, anti-inflammatory agents, disinfectants, probiotics, nutrients and others in the forms of soluble powders, oral liquids, oral tablets and injections. The Company’s products are used for bovine, swine, poultry, fishes and companion animals. It also engages in the leasing of real estate. The Company distributes its products within domestic market and to overseas markets.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
December 6th, 1983
Public Since
November 16th, 2000
No. of Shareholders
15,235
No. of Employees
108
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
12,274,897

044960 Share Price Performance

Upcoming Events for 044960

Q2 2024 Eagle Veterinary Technology Co Ltd Earnings Release

Q3 2024 Eagle Veterinary Technology Co Ltd Earnings Release

Similar to 044960

Picture of AbClon logo

AbClon

kr flag iconKorea Exchange - KOSDAQ

Picture of ADBiotech Co logo

ADBiotech Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Ahn-Gook Pharmaceutical Co logo

Ahn-Gook Pharmaceutical Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Alteogen logo

Alteogen

kr flag iconKorea Exchange - KOSDAQ

Picture of Aminologics Co logo

Aminologics Co

kr flag iconKorea Exchange - KOSDAQ

FAQ